TRULICITY is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
The dosing, monitoring, and protocol adjustments should be managed by a licensed physician not self-directed based on internet research
But isn't it a little stretched to make a weight loss claim based on a trial of 50 SS
Biomed J Sci & Tech Res 49(1)-2023
Now more than ever, it is critically important to meet the millions of people who have not previously chosen obesity medications due to administration preferences where they are," said Dave Moore, Executive Vice President, U.S
Many of them are in the middle of active GLP-1 treatment they have lost weight, experienced metabolic improvements, and are facing the prospect of their progress reversing if they cannot find an affordable continuation pathway before their current supply runs out